Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.

Hiniker SM, Agarwal R, Modlin LA, Gray CC, Harris JP, Million L, Kiamanesh EF, Donaldson SS.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):67-74. doi: 10.1016/j.ijrobp.2014.01.056.

PMID:
24725690
3.

Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia.

Alexander BM, Wechsler D, Braun TM, Levine J, Herman J, Yanik G, Hutchinson R, Pierce LJ.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1191-6. Epub 2005 Jun 22.

PMID:
15978741
4.

Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.

Kumar P, Kun LE, Hustu HO, Mulhern RK, Hancock ML, Coffey D, Rivera GK.

Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):477-83.

PMID:
7852109
5.

Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.

Corvò R, Paoli G, Barra S, Bacigalupo A, Van Lint MT, Franzone P, Frassoni F, Scarpati D, Bacigalupo A, Vitale V.

Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):497-503.

PMID:
10078628
6.

Low-dose cranial boost in high-risk adult acute lymphoblastic leukemia patients undergoing bone marrow transplant.

Su W, Thompson M, Sheu RD, Steinberg A, Isola L, Stock R, Bakst RL.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):103-108. doi: 10.1016/j.prro.2016.06.008. Epub 2016 Jun 23.

PMID:
28274393
7.

Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.

Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B, Reiffers J, Sadoun A, Rohrlich P, Jouet JP, Milpied N, Lutz P, Plouvier E, Cornu G, Vannier JP, Gandemer V, Rubie H, Gratecos N, Leverger G, Stephan JL, Boutard P, Vernant JP.

Br J Haematol. 1998 Aug;102(3):656-65.

PMID:
9722290
8.
10.

The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.

Sanders KE, Ha CS, Cortes-Franco JE, Koller CA, Kantarjian HM, Cox JD.

Cancer. 2004 May 15;100(10):2176-80.

11.

Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia.

Shigematsu A, Tanaka J, Suzuki R, Atsuta Y, Kawase T, Ito YM, Yamashita T, Fukuda T, Kumano K, Iwato K, Yoshiba F, Kanamori H, Kobayashi N, Fukuhara T, Morishima Y, Imamura M.

Int J Hematol. 2011 Nov;94(5):463-71. doi: 10.1007/s12185-011-0944-2. Epub 2011 Nov 1.

PMID:
22042561
12.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.

Biol Blood Marrow Transplant. 2008 Jun;14(6):685-92. doi: 10.1016/j.bbmt.2008.03.011.

13.

Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.

Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC.

J Clin Oncol. 2006 Aug 20;24(24):3858-64. Erratum in: J Clin Oncol. 2006 Nov 10;24(32):5181.

PMID:
16921038
14.
15.

Is veno-occlusive disease incidence influenced by the total-body irradiation technique?

Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.

Strahlenther Onkol. 1995 Dec;171(12):694-7.

PMID:
8545791
16.

Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.

Barredo JC, Devidas M, Lauer SJ, Billett A, Marymont M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey AK.

J Clin Oncol. 2006 Jul 1;24(19):3142-9.

PMID:
16809737
17.

Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.

Fukano R, Nishimura M, Ito N, Nakashima K, Kodama Y, Okamura J, Inagaki J.

Pediatr Transplant. 2014 Aug;18(5):518-23. doi: 10.1111/petr.12276. Epub 2014 May 12.

PMID:
24815062
18.

Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.

Edelstein K, D'agostino N, Bernstein LJ, Nathan PC, Greenberg ML, Hodgson DC, Millar BA, Laperriere N, Spiegler BJ.

J Pediatr Hematol Oncol. 2011 Aug;33(6):450-8. doi: 10.1097/MPH.0b013e31820d86f2.

PMID:
21646917
19.
20.

Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.

Croog VJ, Kramer K, Cheung NK, Kushner BH, Modak S, Souweidane MM, Wolden SL.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):849-54. doi: 10.1016/j.ijrobp.2009.09.005. Epub 2010 Mar 6.

PMID:
20207502

Supplemental Content

Support Center